Clinical Trials Browser

Pioglitazone × Genitourinary × Clear all

NCT02592317 2026-03-13

A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer

Phase 1 Active not recruiting

Prostatic Neoplasms, Castration-Resistant

NCT05098327 2023-08-15

Pioglitazone and Insulin Resistance in ADT

Phase 3 Withdrawn

Diabetes Mellitus, Type 2, Insulin Resistance, Prostatic Neoplasms

NCT04995978 2023-06-23

Insulin Resistance and Androgen Deprivation Therapy

Phase 2 Withdrawn

Insulin Resistance, Prostatic Neoplasms

NCT04658849 2023-05-15

Insulin Resistance Following ADT for Prostate CA

Phase EARLY_PHASE1 Withdrawn

Insulin Resistance, Prostatic Neoplasms

NCT01935466 2022-01-25

PROBE-PIO

Urinary Bladder Neoplasms, Diabetes Mellitus, Type 2

NCT01637935 2018-03-07

Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes

193,099 enrolled 15 charts

Urinary Bladder Neoplasms, Diabetes Mellitus

NCT01911728 2017-06-26

Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates

Phase 1 Completed

Pharmacokinetics of MDV3100